Enevia Health

Contact

Resolving doubts about genetic concepts

Resolving doubts about genetic concepts

Exome: Definition and Concept

The exome refers to the part of the human genome that encodes proteins. It is made up of all the exons, which are the regions of DNA that are transcribed into messenger RNA and eventually translated into proteins. The exome contains vital information for the function and structure of proteins in the body.

Exome analysis and its utility

Exome analysis, known as whole exome sequencing, involves determining the exact order of nitrogenous bases (A, T, C, G) in an individual's exons. This is achieved using next-generation sequencing (NGS) techniques, which make it possible to analyze thousands of genes simultaneously and detect genetic variants, such as mutations and single nucleotide polymorphisms (SNPs), that could be associated with genetic disorders or inherited diseases.

Uses and applications

Exome analysis has several important applications:

  1. Diagnosis of Genetic Diseases: It can help identify genetic variants that cause or are related to rare and complex genetic diseases.
  2. Search for Variants in Multifactorial Diseases: It can provide information on genetic variants that contribute to susceptibility to multifactorial diseases, such as type 2 diabetes or cardiovascular disease.
  3. Precision Medicine: It can guide the treatment and management of patients by identifying genetic variants that affect the response to certain drugs. 

Limitations of Exome Analysis

However, there are limitations to this approach:

  1. Variants of Uncertain Meaning: Not all identified variants have a clear interpretation of their clinical significance.
  2. Non-Coding Variants: The exome is focused only on coding regions, so variants in non-coding regions or in regulatory regions could be missed.
  3. Cost and Scalability: Although more affordable than whole genome sequencing, exome analysis can still be expensive and may not be the best option for all research. 

Clinical exome vs. Whole Exome

Clinical exome focuses on specifically analyzing genes known to be associated with specific genetic disorders or diseases. In contrast, the whole exome analyzes all the exons of the genome, including those for which there is not yet a clear understanding of their relationship with diseases.

The targeted exome

Also known as targeted exome sequencing or exome capture, it is a whole exome sequencing variant. Rather than sequencing all exons present in the genome, exome targeting specifically focuses on sequencing exons of interest, which typically correspond to known genes or specific genomic regions thought to be associated with a particular disease or phenotype.

Instead of whole-exome sequencing, which can be expensive and data-intensive, targeted exome sequencing uses DNA capture probes to selectively isolate regions of interest from the genome prior to sequencing. These probes are designed to bind to the sequences of the exons to be analyzed. Once the probes have bound the regions of interest, the surrounding DNA is washed and sequenced, allowing one to focus on the specific regions to be tested.

Targeted exome sequencing has several applications:

  1. Focus on Candidate Genes: If certain genes are suspected to be related to a specific phenotype or disease, those specific genes can be analyzed instead of whole exome sequencing.
  2. Cost and Efficiency: Compared to whole exome sequencing, targeted exome sequencing can be more cost-effective and generate a more manageable amount of data.
  3. Variants in Families: It may be useful in family genetic studies, where only certain genes or regions may be of interest for the inherited disease in question.
  4. Population Studies: It can be used to investigate specific variants in populations with particular genetic characteristics.

Sequencing and Comparison Techniques

There are several sequencing techniques, such as Illumina (next-generation sequencing), Sanger (traditional sequencing), and PacBio (single-molecule sequencing). Next-generation techniques, such as Illumina, are faster, more affordable, and can generate large amounts of data, which is essential for large-scale genetic analyses. However, traditional sequencing techniques, such as Sanger, are more accurate in identifying unique variations, such as insertions or deletions.

In summary, exome sequencing is a powerful tool in clinical and research genetics, allowing the identification of genetic variants associated with diseases. However, its interpretation requires experience and clinical context to make informed decisions about diagnosis and treatment.

The phenotype in the context of genetics

the phenotype, in the genetic context, refers to the observable and measurable characteristics of an organism, resulting from the interaction between its genes and the environment. These characteristics can include physical traits such as hair color, height, facial shape, as well as behavioral, physiological, and functional traits, such as behavior, susceptibility to certain diseases, response to medications, and more.

The phenotype is the result of how individual genes (alleles) interact with each other and how they interact with environmental factors, such as nutrition, exposure to toxins, temperature, lifestyle, etc. Therefore, the phenotype is not just a consequence of genetics, but a complex combination of genetics and environment.

There is no fixed number of phenotypes, since the observable characteristics can be practically infinite and vary depending on the genes present in an individual's genome and how they are expressed and modified by environmental factors. Each individual has a unique set of phenotypes that reflects their genotype (set of genes) and their experiences and exposures throughout their lives.

In genetics, a distinction is often made between the observed phenotype (phenotypic phenotype) and the genotype (combination of genes). The relationship between genotype and phenotype is complex and can vary widely due to differential gene expression, gene interactions, and the influence of the environment.

The autistic phenotype

The term "autistic phenotype" it is used to describe the observable characteristics and traits associated with autism spectrum disorder (ASD). ASD is a neurodevelopmental disorder that affects communication, social interaction and behavior of those who suffer from it. Due to the heterogeneous nature of ASD, the autistic phenotype can vary widely between individuals and manifest itself in different ways. Some of the common traits and characteristics associated with the autistic phenotype include:

  1. Communication Difficulties:
    • Deficits in language development, which can range from the complete absence of language to the use of repetitive or echolalic language.
    • Difficulty understanding and using language in a socially appropriate way.
    • Limited nonverbal communication, such as eye contact, gestures, and facial expressions.
  2. Difficulties in Social Interaction:
    • Difficulty establishing social relationships and understanding social cues.
    • Lack of empathy and understanding of the emotions and perspectives of others.
    • Unusual social behavior patterns, such as avoiding eye contact or having difficulty participating in group conversations.
  3. Repetitive Behaviors and Routines:
    • Participation in repetitive and stereotyped activities, such as swinging, spinning objects, or lining things up.
    • Need to maintain consistent routines and rituals, and anxiety about changes.
  4. Specific Interests and Fixations:
    • Intense focus on specific and often unusual interests, sometimes at the expense of other aspects of life.
    • They may have deep and detailed knowledge in specific areas. 

It is important to note that the autistic phenotype is highly variable and not all individuals with ASD will display all of these traits. Some may have milder or more intense symptoms in different areas

exome targeting ASD

ASD-targeted exome analysis can be performed to investigate the genetic basis of autism spectrum disorder (ASD) and look for genetic variants that are associated with this phenotype. When exome targeting the ASD phenotype is performed, it generally focuses on investigating genomic regions known to be associated with genetic predisposition to ASD or related neuropsychiatric disorders. These clinical areas or regions of interest may include:

  1. Candidate genes: Specific genes that have previously been identified as candidates to be involved in ASD are analyzed. These genes are often related to brain function, neural communication, and the regulation of brain plasticity.
  2. Chromosomal Regions: Chromosomal regions that have been associated with ASD are investigated through association studies or karyotype analysis. For example, certain deletions or duplications in specific chromosomal regions may be associated with ASD.
  3. Rare and De Novo Variants: We look for rare and de novo (appearing for the first time in the affected individual) genetic variants that may contribute to ASD. These variants could affect the function of key genes for brain development and neural function.
  4. Pathways and Gene Networks: Genetic pathways and gene networks that may be involved in brain development and cognitive functions are explored. Disruption of these pathways may contribute to the ASD phenotype.
  5. Functional Genomics: The function of specific genomic regions, such as promoters and regulatory elements, that could influence ASD-related gene expression is discussed. 

It is important to note that ASD is a complex and heterogeneous disorder, which means that there is no single gene or variant that explains all cases of ASD. Instead, multiple genes and genetic variants, in interaction with environmental factors, are believed to contribute to the development of ASD. Performing an exome targeting of the ASD phenotype seeks to identify genetic patterns that might be present in certain subgroups of people with ASD and provide valuable information on underlying biological processes.

This type of analysis can help to better understand the genetics of ASD, identify genetic biomarkers, and allow for more personalized and effective interventions.

share this news

Other interesting news

Blog Categories

Test

ASD

Supplements

Immune system

Resources

Chelators

Practitioners

Omegas

News

Neurostimulation

Microbiota

Laboratories

Stories

Genetics

Diet

Conferences

celiac disease

ATEC

Akkermansia

CONTACT

We will reply as soon as possible.

ENEVIA HEALTH as Data Controller will process your data in order to manage your registration as a registered user. The basis of legitimacy is your consent expressed in the acceptance box of our privacy policy. The communication of the data is not foreseen, except in compliance with legal obligations. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Privacy Policy.

Enevia Health, LLC

30 N Gould Ste N, Sheridan, WY 82801, USA

Exclusive professionals

Your request will be reviewed by our team.

Username*
Name*
Surnames*
E-mail*
Professional title (doctor, nutritionist, therapist...)*
Collegiate number*
Specialty
Name of clinical practice*
Address of the clinical practice where the kits are sent.*
Password*
Confirm Password*
ENEVIA HEALTH as Data Controller will process your data in order to manage your registration as a registered user. The basis of legitimacy is your consent expressed in the acceptance box of our privacy policy. The communication of the data is not foreseen, except in compliance with legal obligations. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Privacy Policy.

Exclusive Laboratories

Your request will be reviewed by our team.

Laboratory Name*
laboratory manager*
Laboratory medical director*
Membership number Medical Director*
Telephone*
Laboratory Management*
Location*
Province*
Country*
E-mail*
Username*
used for login
Password*
Confirm Password*
ENEVIA HEALTH as Data Controller will process your data in order to manage your registration as a registered user. The basis of legitimacy is your consent expressed in the acceptance box of our privacy policy. The communication of the data is not foreseen, except in compliance with legal obligations. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Privacy Policy.
Whatsapp groups

Our groups are the ideal platform to learn and share your scientific concerns about neurodevelopment issues

Group rules:

  1. Be nice. Bullying, insults and personal confrontations are not allowed.
  2. Respect everyone's privacy.
  3. Use information that is as scientific and reliable as possible, cite sources.
  4. We want to comply with WhatsApp rules and avoid topics that we know lead to the closure of groups, so we ask that these groups not discuss topics related to VACCINES, MMS, CDS.

*Our purpose is informational only, it is not intended to be a substitute for medical advice, diagnosis or treatment.

User from Spain

We are working on our website. For any queries, you can contact our customer service team at atencionalcliente@eneviahealth.com